In this issue:
Flex Up supports flexible adjustment of upadacitinib dosing
Dupilumab may have growth-preserving benefits in paediatric patients
Reduced risk of infections with dupilumab vs conventional therapies
Palmar hyperlinearity linked to risk for paediatric AD
Risk of thromboembolic events with JAK inhibitors
Can paediatric eczema herpeticum be managed in the outpatient setting?
Melatonin use is common in paediatric patients but may not be effective
Dupilumab-associated ocular surface disease is common
Comparative efficacy of monotherapies for chronic hand eczema
Hazardous chemicals prevalent in clothing and textiles
Please login below to download this issue (PDF)